Skip to content

comparison of the efficacy &effectiveness of clomiphen citrate and recombinant FSH in infertile women candidated for IUI

Comparison of the efficacy &effectiveness of clomiphen citrate and recombinant FSH in infertile women candidated for IUI refering to infertility clinic of vali e asr hospital

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201211135181N8
Enrollment
100
Registered
2015-08-15
Start date
2015-01-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

female infertility. Female infertility associated with anovulation

Interventions

Intervention 1: in Interventional Group 1: with daily usage of 50 mg Clomiphen citrate oral tablet from 3rd to 7th day of menstrual cycle. Intervention 2: In intervention Group 2: Subcutaneously D
Treatment - Drugs
in Interventional Group 1: with daily usage of 50 mg Clomiphen citrate oral tablet from 3rd to 7th day of menstrual cycle.
In intervention Group 2: Subcutaneously Daily injection of 75IU Recombinant Gonadotropine from 4th day of menstrual cycle.

Sponsors

Vice Chanceler for Research Tehran university of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age lower than 40 years ; the first cycle of treatment;primary infertility; duration of infertility 7.2;viscosity20000000/ml; total sperm count>40000000;motility>50%;forward progresion>2 ; normal morphology>50% ;round cell<5000000/ml;sperm aglutination<2) mild male factor . Exclusion criteria: moderate to severe endometriosis diagnosed with laparascopy;history of prior abdominal or gynecological surgery;history of PID; history of allergy or contraindication for hormonal drug usage .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Clinical pregnancy. Timepoint: 6-7 weeks after IUI(intra uterine insemination). Method of measurement: sonography and geststional sac detection.;Chemical pregnancy. Timepoint: 2-3 weeks after IUI. Method of measurement: labratory test.;Ongoing pregnancy rate. Timepoint: 20 weeks after IUI. Method of measurement: SONOGRAPHY.

Secondary

MeasureTime frame
Abortion. Timepoint: 20th week of pregnancy. Method of measurement: follow up the patient and do sonography.;Multi gestation pregnancy. Timepoint: 6-7weeks after IUI. Method of measurement: sonography and detection several gestational sacs.;Live birth rate. Timepoint: 36-40th week of pregnancy. Method of measurement: follow up the patient.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBahareh Khandzad

Tehran University of Medical Sciences

b_khandzad@yahoo.com+98 21 6693 9320

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026